Are You Experiencing Night Time Low Blood Sugar Levels?
The purpose of the study is to evaluate the safety and effectiveness of an investigational drug in reducing episodes of night time low blood sugar (nocturnal hypoglycemia) in adults with type 1 diabetes.
New Type 1 Diabetes Study
New Type 1 Diabetes Study Enrolling Now in West Palm Beach, FL
Adults 18 to 79 years of age with type 1 diabetes may qualify to take part in a research study comparing an investigational short-acting mealtime insulin with Humalog insulin for approximately 34 weeks.
Qualified candidates will:
• Be on Multiple Daily lnjections of long and short-acting insulin
• Be willing to use a continuous glucose monitor
• Have access to a Smart Phone
• Receive free Dexcom G7 continuous glucose monitoring systems throughout the study
• Not be on any weight loss medications such as GLP-1 receptor agonists or glucose-modifying medications such as SGL T-2 inhibitors
Additional eligibility criteria also apply.
Participants will be compensated up to $1,000 for their time and travel and will receive insulin at no cost.
For more information call Metabolic Research Institute Inc. (561) 802-3060, ext. 8036 or visit: www.metabolic-institute.com/type1-diabetes-study/
Underactive Thyroid – Hypothyroidism
Underactive Thyroid (Hypothyroidism) Clinical Study Enrolling Now in West Palm Beach, Florida
Metabolic Research Institute Inc. is looking for adults 18-75 years of age with a diagnosis of hypothyroidism who have been taking Levothyroxine for 1 year.
The clinical research study will compare the safety and effectiveness of two thyroid medications in adults diagnosed with hypothyroidism.
For more information, call Metabolic Research Institute Inc. (561) 802-3060, ext. 8036 or visit: www.metabolic-institute.com/hypothyroidism/
New Vitiligo Study
Metabolic Research Institute Inc. in West Palm Beach, FL is currently enrolling adult volunteers in a clinical research study evaluating the safety and effectiveness of an investigational oral medication for the treatment of Nonsegmental Vitiligo.
Qualified candidates will be:
men and women 18 years of age or older
diagnosed with Nonsegmental Vitiligo